Skip to main content

Table 5 Multivariate analysis of overall survival between tamoxifen (TAM) and toremifene (TOR) treated patients

From: A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrospective cohort study

  HR(95%CI) P value
Age 1.012(0.859-1.192) 0.887
T 0.873(0.156-4.873) 0.877
Grade 1.025(0.376-2.793) 0.962
N 1.656(0.586-4.678) 0.341
Her-2 1.096(0.891-1.347) 0.387
Local control 0.630(0.150-2.643) 0.528
Chemotherapy 0.993(0.441-2.234) 0.987
TAM-TOR 0.000(0.000-6E + 174) 0.955